Eligo Bioscience Awarded $5 Million to Advance Breakthrough Genetic Medicine Platform for Immuno-Dermatology

Eligo Bioscience United States of America Canada France Germany Spain United Kingdom South Korea

Funding is part of the call for proposals "Innovations in Biotherapies and Bioproduction," coordinated by the Health Innovation Agency under France 2030 strategy, operated on behalf of the French government by BpifranceView original content:https://www.prnewswire.co.uk/news-releases/eligo-bioscience-awarded-5-million-to-advance-breakthrough-genetic-medicine-platform-for-immuno-dermatology-302452485.html